ARCHIVES

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 1 | January 29, 2010

Download PDF Visit The Full Archive

Related Articles

GM To Offer Three Awards of $1000,000 Each To Cancer Investigators

September 8, 1978

Stop Cancer Changes Leaders, Focus, Sends $1.6M To NCI

August 30, 1991

DCT Board Approves New Imaging Study In Split Vote, Small Grant Program

October 27, 1989

ACS Awards Grants To Wisconsin, USC For Behavior Research

July 16, 1993

In Brief: Tipping Resigns Forom ACS; Vaughan Joins UAB BMT Program; PCI Recruits Ball, Finn, Mirro

September 20, 1991

NCI Outlines Need For $3,873 Billion To Seize Cancer Research Opportunities

October 30, 1998